"Targeting S. maltophilia Biofilms with Phage Bfi2" by Lydia Walther
College of Science and Health Theses and Dissertations

Date of Award

Summer 8-20-2023

Degree Type

Thesis

Degree Name

Master of Science (MS)

Department

Biological Science

First Advisor

Joanna Brooke, PhD

Second Advisor

Timothy Sparkes, PhD

Third Advisor

Megan Schrementi, PhD

Abstract

Stenotrophomonas maltophilia is a multidrug resistant bacterium which can cause severe infections of the respiratory tract, soft tissue, and bloodstream, and its ability to form biofilms on medical implants and devices contributes to its role as a hospital-acquired pathogen (Brooke, 2021; Flores-Treviño et al., 2019). The rise of antibiotic resistance has prompted the search for new treatments against bacteria. Bacteriophages, or phages, are a promising alternative to antibiotics because they infect and kill bacteria (Ling et al., 2022). Phage therapy has gained recent attention as a life-saving treatment for antibiotic resistant infections (Racenis et al., 2023; Schooley et al., 2017). Phage Bfi2 (Biofilm formation inhibitor 2) is a novel virus that infects S. maltophilia. This thesis characterizes Bfi2, its life cycle, its activity against biofilm, and effectiveness when combined with antibiotics. Transmission electron microscopy revealed a virus with an icosahedral head and long, flexible non-contractile tail, classifying Bfi2 as a siphovirus within the Caudoviricetes class. Bfi2 is a virulent phage that forms clear plaques on lawns of S. maltophilia, and a one-step growth curve depicted a latent period of 60 minutes and a burst size of ~33 virions/cell. The phage inhibits the formation of S. maltophilia biofilm biomass and reduces the metabolic activity of 24-hour preformed biofilms. When testing its ability to inhibit planktonic growth and biofilm formation in combination with antibiotics, the activity of Bfi2 was not enhanced with any one of the five antibiotics chosen. Further work is needed to characterize the phage, but these results demonstrate its potential for phage therapy against S. maltophilia infections.

SLP Collection

no

Included in

Biology Commons

Share

COinS